Bioethics News

German Practitioner Suspected of Killing Patients with Experimental Drug

August 26, 2016

(Reuters) – The head of an alternative cancer treatment center in Germany is under investigation after three patients died there in suspicious circumstances, German prosecutors said on Friday. The non-medical practitioner, identified as Klaus R., is suspected of manslaughter in three cases and negligent injury in the case of two more patients who remain in serious condition, said Axel Stahl, senior prosecutor in the Krefeld prosecutor’s office.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.